Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results.
Nuwellis says it will convene a Pediatric Medical & Nursing Advisory Board on Nov. 18–19, 2026 to guide development of its Vivian pediatric CRRT platform, as part of a broader pediatric strategy that includes a proposed Aquadex label expansion for patients ≥5 kg.
Nuwellis said it will convene a pediatric medical and nursing advisory board to advance development of its Vivian™ pediatric CRRT system. The company framed the move as part of its broader pediatric strategy.
MINNEAPOLIS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced that it will convene a Medical & Nursing Advisory Board on November 18--19, 2026, to support the continued development of
Nuwellis (NUWE) will convene a Pediatric Medical & Nursing Advisory Board to advance development of its Vivian™ Pediatric CRRT system.